But with Novartis failing to convince European regulators about the merits of Xiidra last year, and Allergan's ... a phase 3 trial for eye drops containing tivanisiran, in dry eye disease associat ...

If left untreated, severe dry eyes can lead to eye pain ... mucin and water – a totally new MOA, delivered as drops. Restasis, from Allergan, has been a blockbuster for many years in the ...

NORTH CHICAGO, Ill., Jan. 29, 2025 /PRNewswire/ -- In response to growing demand for personalized, patient-centric aesthetic solutions 1,2, Allergan Aesthetics, an AbbVie Company, is proud to ...

Aggressive treatment before ocular surgery helps avoid postoperative issues with visual quality in patients with dry eye ...

Just 10 minutes a day with this electric heated eye mask can help your eyes produce more tears naturally — and it's 20% off.

A couple drops in your eye usually brings relief, not concern—but a rare recall case highlights the importance of a clean, ...

One patient with dry eye can generate $421 in annual revenue for a practice. Other ocular conditions may be identified during dry eye visits. KOLOA, Hawaii — Building a dry eye clinic presents a ...

You are responsible for reading, understanding, and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy ...

People over age 50, women, and those who wear contact lenses are especially prone to dry eye. Doctors say you can use eye drops called artificial tears if your eyes feel dry. 5. Check your ...

New AA (Allergan Aesthetics) Signature Program provides a personalized approach to treatment planning, in combination with Allergan Aesthetics’ advanced facial portfolio to address patient needs and ...

We strive to have a remarkable impact on people’s lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics ...

A whistleblower lost his bid to reinstate a False Claims Act suit alleging that Allergan Inc. and Adamas Pharmaceuticals Inc. fraudulently obtained patents on two drugs to combat Alzheimer’s disease.